More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.00B
EPS
-2.68
P/E ratio
--
Price to sales
2.69
Dividend yield
--
Beta
1.469192
Previous close
$43.86
Today's open
$44.26
Day's range
$43.15 - $45.68
52 week range
$15.93 - $50.06
show more
CEO
Martin Madaus
Employees
2900
Headquarters
Burlington, MA
Exchange
Nasdaq Global Select
Shares outstanding
43808393
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
New York, New York--(Newsfile Corp. - November 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Newsfile Corp • 12 hours ago

Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Nov. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.
GlobeNewsWire • Nov 15, 2026

ROSEN, A LONGSTANDING LAW FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
New York, New York--(Newsfile Corp. - November 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Newsfile Corp • Nov 14, 2026

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
New York, New York--(Newsfile Corp. - November 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Newsfile Corp • Nov 13, 2026

Why Azenta Stock Crushed it on Wednesday
Wednesday was an ideal day to be invested in Azenta's (AZTA +20.80%) stock. Investors fell over themselves buying shares of the healthcare tech company, and when the scramble subsided, the stock had gained almost 21%.
The Motley Fool • Nov 12, 2026

What Azenta (AZTA) Said on Its Q4 Earnings Call
Azenta NASDAQ: AZTA forecast faster organic revenue growth and higher profitability for fiscal 2027 after fourth-quarter sales exceeded expectations, as the company works to improve its automated storage business and expand its gene synthesis capabilities.
MarketBeat • Nov 11, 2026

Azenta, Inc. (AZTA) Q4 2026 Earnings Call Transcript
Azenta, Inc. ( AZTA ) Q4 2026 Earnings Call November 11, 2026 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations Martin Madaus - Interim President, CEO & Director William Martin - Senior Vice President & President of Multiomics Lawrence Lin - Executive VP & CFO Conference Call Participants David Saxon - Needham & Company, LLC, Research Division Matthew Stanton - Jefferies LLC, Research Division Steven Etoch - Stephens Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Matthew Parisi - KeyBanc Capital Markets Inc., Research Division Brendan Smith - TD Cowen, Research Division Presentation Operator Greetings, and welcome to Azenta Fourth Quarter 2026 Fiscal Financial Results. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, November 11, 2026.
Seeking Alpha • Nov 11, 2026

Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.
Q4'26 reported revenue growth of 5% year over year and 2% on an organic basis FY'26 reported revenue growth of 5% year over year and 2% on an organic basis FY'27 reported revenue expected to range from $648 to $660 million FY'27 organic revenue growth expected to range between 3% to 5% year over year FY'27 adjusted EBITDA margin expected to expand approximately 200 to 250 basis points year over year BURLINGTON, Mass., Nov. 10, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2026.
PRNewsWire • Nov 10, 2026

ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
New York, New York--(Newsfile Corp. - November 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Newsfile Corp • Nov 10, 2026

Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
NEW YORK, Nov. 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. So what: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
PRNewsWire • Nov 8, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Azenta Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.